))
This Week's Headlines: July 26, 2021
Manage episode 407440810 series 3560288
Content provided by Healio, Abhishek Bhardwaj, and MD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Healio, Abhishek Bhardwaj, and MD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
This week, CHEST issues guidelines for low-dose CT screening for lung cancer; severe COVID-19 survivors experience pulmonary impairment; the FDA approves Prograf to prevent lung transplant rejection; and more.
Read the full coverage here:
CHEST issues new guideline on benefits, harms, use of low-dose CT screening for lung cancer
Pulmonary impairment ‘highly prevalent’ in severe COVID-19 survivors following discharge
FDA approves Prograf to prevent organ rejection in lung transplant recipients
In omega-3 fatty acid trials, EPA alone yields greater CV risk reduction vs. EPA plus DHA
Benefit of full-dose heparin for patients with COVID-19 warrants ‘new standard of care’
References:
González J, et al. Chest. 2021;doi:10.1016/j.chest.2021.02.062.
Khan SU, et al. eClinical Medicine. 2021;doi:10.1016/j.eclinm.2021.100997.
Mazzone PJ, et al. Chest. 2021;doi:10.1016/j.chest.2021.06.063.
Sholzberg M, et al. medRxiv. 2021;doi:10.1101/2021.07.08.21259351.
34 episodes
Share
